Perfect. Thanks, Gio. Turning to slide nine, this slide summarizes our fourth-quarter financial results. Adjusted EPS of $0.99, which was 77% higher than last year's fourth quarter. And this was primarily driven by higher adjusted operating profit, but also, continuing the balance sheet theme, favorably influenced by lower interest expenses, strong free cash flow, and improved balance sheet allowed us to execute two-term loan repricings in the past twelve months. Our organic net sale increased approximately 27% driven by double-digit growth across all three regions with EMEA leading the way at 33%. Fourth-quarter sales were more than $200 million higher than the midpoint with upside across all three regions. As we entered the fourth quarter, we certainly had the backlog and the capacity to over-deliver on our expectations. But we also had a significant number of new product launches, which sometimes introduces timing risk. And sometimes customers request a deferral of year-end shipments from December into January. However, our customers generally wanted product as soon as available, and our plants executed exceptionally well to mitigate new product launch risk. And as a result, we significantly over-delivered the top line across all three regions. Approximately $200 million higher than what we guided. Adjusted operating profit of $504 million was 53% higher than last year. And this was driven by higher volume and continued improvement in commercial execution, including price cost. Adjusted operating margin of 21.5%, up 380 basis points from the fourth quarter of 2023. A hundred and ten basis points higher than guidance. Certainly provides a very strong foundation for 2025. We generated $362 million of adjusted free cash in the quarter. A hundred and thirty-five million dollars higher than guidance, driven by higher adjusted operating profit and continued improvement with trade working capital, which includes accounts receivable, inventory, accounts payable, and deferred revenue. Trade working capital as a percentage of annualized fourth-quarter sales declined to 13.1% at year-end down from 18.5% at the end of 2023. So good progress with working capital in 2024. But as always, never satisfied, and there's still a ton of opportunity going forward. Next, turning to slide ten, this slide summarizes our fourth-quarter segment results. As mentioned, we saw robust top-line growth across all three regions each one up more than 25% from last year's fourth quarter. Americas had another strong quarter. Organic sales up 25%. With growth continuing in a convincing way across colocation and hyperscale markets. Adjusted operating margin in the Americas expanded 420 basis points to 25.6% driven by commercial execution and operational leverage. Moving to the right on the slide, APAC sales increased 27% organically with strength throughout the region, including China, which grew in the upper teens from last year's fourth quarter. While we are certainly pleased to see this growth in China, we are not comp it is an inflection point. We still see broad economic uncertainty as we enter 2025. But we continue to monitor signs of market growth and green shoots. So I guess I can invoke the obligatory CFO statement related to China. We are cautiously optimistic. Top-line growth in India and the rest of Asia, continue to be strong as AI starts its penetration in those regions. And we believe, based upon our strong AI value proposition, we will continue to expand market share across both India and the rest of Asia. APAC's adjusted operating margin increased 260 basis points from last year's fourth quarter with benefits from operational leverage and regional mix. Finally, to the far right, EMEA organic sales, increased 33%. Was driven by strong demand from colocation and hyperscale customers across several product lines, but notably Switchgear. Adjusted operating margin for EMEA increased 370 basis points with benefits from operational leverage and productivity. EMEA once again prevailed in the March but we expect the 2025 race to become increasingly competitive, and we look forward to continue improvement in both regions. Next, turning to slide eleven. This provides a summary of full-year 2024 results. It was another strong year across the board. And at this time last year, I mentioned how it is always a good thing on this slide when the orange bars are significantly higher than the gray bars, and we are pleased to see this once again for 2024 versus 2023. And unless we switch colors, we expect this to be the case going forward. Including in 2025, which we will review in just a few moments. 2024 adjusted EPS of $2.85. Represents a 61% increase from prior year. Primarily driven by higher adjusted operating profit, but also favorably influenced by lower interest expense as I mentioned a few slides back. Organic sales were up 18% with strong performance across all three regions, all double digits higher. Demonstrating that we are well positioned and winning in our end market across the globe. Adjusted operating profit increased by nearly a half a billion dollars with adjusted operating margin of 19.4%, up 410 basis points from 2023. Driven by both improved variable contribution margin and lower fixed cost as a percentage of sales. Our 2024 margin performance including exiting the year at 21.5%, provides confidence for our full-year 2025 margin guidance of 21%. As well as our long-term target of 25% by 2029. Last year, we experienced a step function in our adjusted free cash flow. We took another step upwards in 2024. We generated over $1.1 billion in adjusted free cash flow this past year which translates into a conversion of 103% after converting 114% last year. Our net leverage at the end of 2024 was approximately 1x. So we continue to execute well. Building a track record of financial strength and consistency. Which provides significant flexibility with capital deployment, as Gio mentioned. While also developing a balance sheet to achieve investment-grade ratings. Before moving off this slide, looking one last time at the numbers on the slide, it's hard not to be pleased with our results. EPS up 61%, Sales up 18%, AOP up 47%, and cash flow up 46%. It is a testament to our strategy and execution in hopefully, it instills confidence that we honor our financial commitments. Once again, pleased but never satisfied. 2024 is now behind us. In fact, we are already planning for 2026, but we still need to execute this year, and we summarize our outlook for 2025 in the next two slides. Moving to page twelve, this slide summarizes our first-quarter guidance. And for avoidance of doubt, this first quarter and full-year guidance does not contemplate any recent or proposed changes in policies by the current US administration including the potential impact from tariffs, with the exception of incremental direct tariffs on China imports, which have a relatively immaterial impact on our financials. We are expecting adjusted EPS of $0.60, up for the first quarter, up 40% from last year. And that's primarily driven by higher adjusted operating profit. First-quarter organic sales are expected to be up 19% with Americas up in the low twenties, APAC mid-twenties, and EMEA low teens with this organic growth offset by an approximately $30 million foreign exchange headwind. We anticipate first-quarter adjusted operating profit of $325 million and adjusted operating margin of 16.9%, up 170 basis points from last year's first quarter. And although we do not provide explicit guidance, we expect first-quarter adjusted free cash flow to be slightly higher than the first quarter of 2024. Next, turning to slide thirteen, our full-year 2025 guidance. All metrics are relatively consistent with the preliminary outlook we provided at our November investor event. Reconfirming our confidence in the market backdrop and our ability to exit Q. Our adjusted EPS is expected to be $3.55 at the midpoint. 25% higher than 2024. With this increase primarily driven by higher adjusted operating profit and lower interest partially offset by higher share count from the warrant exercise in the fourth quarter. 2025 sales are projected to be approximately $9.2 billion at the midpoint. Approximately $75 million higher than the implied sales guidance in November. And this increase is despite an estimated incremental $125 million foreign exchange headwind. So on an absolute dollar basis, organic sales are up approximately $200 million from our November outlook. Of course, our full-year organic growth is lower on a per percentage basis from what we presented a few months ago, 16% at the midpoint versus 17%. But this is primarily due to the significant $200 million top-line beat in the fourth quarter. Maybe from another perspective, if we compare our current 2025 sales guidance to the $2.8 billion we expected for 2024 in November, organic sales in 2025 actually claims to 19% on an apples-to-apples basis. Once again, on a dollar basis, our outlook for organic sales is approximately $200 million higher today than in November, and this is reflective of our growing confidence in the market. And our ability to continue to drive value for our customers. On a regional basis, we expect the Americas to continue strong growth in the low twenties, low teens growth in APAC is primarily driven by India and the rest of Asia, and after strong top-line growth in 2024 of 21%, including 33% in the fourth quarter, we expect high single-digit growth in EMEA based upon more challenging comparables, but we continue to monitor, catalysts for higher growth in that region as AI expands within that market and we have better visibility as we progress through the year. Adjusted operating profit expected to be up 25% to $1.935 billion consistent with the midpoint of our 2025 outlook we provided November, and once again, similar to sales, we are covering incremental foreign exchange headwind in adjusted operating profit driven by a stronger US dollar. Tire year-over-year adjusted operating profit is primarily driven by volume commercial execution, and productivity, partially offset by higher OpEx investment and growth capacity and ER&D which we expect to be approximately $160 million combined in 2025. We are projecting adjusted free cash flow of $1.3 billion at the midpoint. Including $275 million in CapEx or 3% of sales, demonstrating our continued commitment to invest in the growing market. Once again, we expect another year where the orange bars are nicely above the gray bars. And this projected strong performance in 2025 should further solidify a strong foundation for continued top-line and bottom-line growth in 2026, and beyond. So with that said, I turn it back over to Gio.